Annual Financial Report

RNS Number : 6330I
British Smaller Companies VCT2 Plc
27 March 2015
 

 

 

BRITISH SMALLER COMPANIES VCT2 PLC

Annual Financial Report Announcement for

the Year ended 31 December 2014

 

British Smaller Companies VCT2 plc ("the Company") today announces its audited results for the year ended 31 December 2014.

Financial Highlights

·     An increase in total return of 1.7 per cent to 106.4 pence per ordinary share (2013: 104.6 pence per ordinary share).

·     An increase in net asset value of 1.8 pence per ordinary share prior to the payment of dividends, representing a 2.7 per cent increase on the opening net asset value.

·     Total dividends paid in the year of 4.5 pence per ordinary share (2013: 4.5 pence per ordinary share).

·     Total cumulative dividends paid since inception of 43.5 pence per ordinary share (2013: 39.0 pence per ordinary share).

·     Proposed final dividend of 2.5 pence per ordinary share in respect of the year ended 31 December 2014.

·     Successful  joint fundraising with British Smaller Companies VCT plc  during the year, raising new funds of £10.2 million for the Company. Following the excellent response to the  fundraising launched on 20 October 2014 with British Smaller Companies VCT plc the offers were fully subscribed on 24 March 2015 raising £40 million in aggregate.

·     The Company invested a total of £13.6 million into 16  companies during the year, including £12.46 million into 11 new companies and £1.14 million of follow-on investment to support the existing portfolio.

·     Successful realisation of the Company's investment in Waterfall Services Limited. Total proceeds of £1.33 million on the original investment of £0.25 million generated a 5.3x return.

 



Strategic Report

The Company is pleased to present its Strategic Report for the year ended 31 December 2014.  The purpose of this report is to inform shareholders and help them to assess how the directors have performed in their duty to promote the success of the Company.  This Report has been prepared by the directors in accordance with section 414 of the Companies Act 2006.

 

Chairman's Statement

Improved economic conditions in  2014 were the background for a very active period for the Company resulting in a positive evolution of the shape of the portfolio.  The share offer, which closed on 29 May 2014, raised new funds of £10.2 million. A total of £13.6 million was  invested during the year to 31 December 2014 of which £8.1 million was invested in the second half of the year. The eleven new investments made in the year continue our strategy of sector and geographical diversity, with businesses in Scotland, Wales, Cambridgeshire, the Midlands, Yorkshire and London all receiving investment.  As at 31 December 2014 the portfolio value was £28.2 million (72 per cent of net assets) which compares to £16.3 million (53 per cent of net assets) a year earlier. 

 

One of the objectives of the Company in building the portfolio is to increase the level of income it receives. I am pleased to report that the majority of new investments include a significant proportion of yielding loans and preference shares. As a result the portfolio income has increased to £1.27 million in the year to 31 December 2014 compared to £0.69 million in 2013. With the benefit of a full year's income from these investments this trend is expected to continue into 2015.  The 2014 income exceeded the administrative expenses of the Company by £0.18 million compared to a shortfall of £0.21 million in 2013. Realised gains of £0.87 million increased the surplus to £1.05 million with unrealised gains of £0.11 million taking the aggregate profit for the year to £1.16 million.

 

Following the strong investment rate in 2014, which is expected to continue into 2015, the Board launched a further share offer alongside British Smaller Companies VCT plc in October 2014 which was fully subscribed by 24 March 2015.   These additional funds will ensure that the Company remains well positioned to take advantage of new investment opportunities and to support the portfolio in the coming year.  Additionally the increased scale and diversity of the Company will help to underpin consistent returns and improve efficiencies.

 

Financial Results

 

In the year to 31 December 2014 the Company's total return increased by 1.8 pence per ordinary share to 106.4 pence per ordinary share, driven mainly by underlying value growth in the investment portfolio. This equates to an increase of 2.7 per cent on the opening net asset value at 31 December 2013.

During the year the Company has paid total dividends of 4.5 pence per ordinary share, bringing the total cumulative dividends paid since inception to 43.5 pence per ordinary share.  The net asset value at 31 December 2014 is 62.9 pence per share as summarised in the table below:

 

 


Pence per ordinary share

£000

NAV at 31 December 2013


65.6


30,458

Net underlying increase in portfolio

1.6


  981


Net income

            0.3


176


Issue/buy-back of new shares

          (0.1)


10,512



1.8


 11,669


Dividends paid

(4.5)


  (2,794)




(2.7)


8,875

NAV at 31 December 2014


62.9


39,333






The chart on page 11 of the annual report shows in greater detail the movement in total return, net asset value and dividends paid over time.

The investments held at 31 December 2013, amounting to £17.15 million, have over the year increased by £0.98 million to £18.13 million at 31 December 2014. This return comprises a gain over the opening value from the realisation of investments of £0.87 million, and a gain on the revaluation of portfolios of £0.11 million. Strong value gains were seen across many portfolio businesses, as a result of improved trading results and delivery of value growth strategies; these were however partially offset by a decline in the value of two businesses, Seven Technologies Holdings Limited and Deep-Secure Limited, due primarily to a freeze in defence sector spending.

 

Shareholder Relations

Dividends

Your Board remains committed to achieving the objective of a consistent and, where possible, increasing dividend stream over time whilst seeking to maintain capital value. Dividends paid in the year comprise a final dividend of 2.5 pence per ordinary share in respect of the year ended 31 December 2013, and an interim dividend of 2.0 pence per ordinary share in respect of the financial year just ended, totalling 4.5 pence per ordinary share. This represents 6.9 per cent of the opening net asset value per ordinary share and brings the cumulative dividends paid to 43.5 pence per ordinary share.

 

The Board is pleased to propose a final dividend of 2.5 pence per ordinary share for the year ended 31 December 2014. This final dividend is subject to approval by the shareholders at the forthcoming Annual General Meeting and if approved will then be paid on 8 June 2015 to shareholders on the register at 8 May 2015. The ex-dividend date is 7 May 2015.

 

Dividend Re-Investment Scheme ("DRIS")

The Company operates a DRIS, which gives shareholders the opportunity to re-invest any cash dividends as described on page 2 of the annual report. The DRIS is open to all shareholders, including those who invested under the recent share offers. For the financial year ending 31 December 2014 dividends totalling £0.4 million were invested in the Company by way of the DRIS.

Fundraising

 

In the light of the continued strong demand for investment from UK businesses your Company launched a prospectus offer on 20 October 2014 alongside British Smaller Companies VCT plc, to increase its investment capacity.  The Company and British Smaller Companies VCT plc received an excellent response and the offers were fully subscribed on 24 March 2015 raising £40 million in aggregate.

 

Shareholder Communications

Your Board remains committed to enhancing shareholder communications and holds shareholder workshops where investors are invited to meet members of the Board, representatives from YFM Private Equity Limited ("the Investment Adviser") and the CEOs of one or more of our investee companies. Our 20th shareholder workshop was held at Freemasons' Hall, London on 4 February 2015 and achieved the highest ever attendance with over 200 shareholders attending. Presentations at the workshop were made by Andrew Barker MD of Mangar International, Rachel McCorry CEO of IO Outsourcing, Michael Green Commercial Director and Matt Guise Sales Director of Macro Art. After lunch, David Hall presented on behalf of the Investment Adviser, followed by a Question and Answer session hosted by David Hall, David Bell and Paul Cannings, all of the Investment Adviser.

 

The Annual General Meeting of the Company will be held at 12.00 noon on 15 May 2015 at 33 St James Square, London, SW1Y 4JS. Full details of the agenda for this meeting are included in the Notice of the Annual General Meeting on pages 74 to 76 of the annual report.

 

Regulatory

 

On 21 July 2014 the Financial Conduct Authority approved the Company's application to become a Small Registered UK Alternative Investment Fund Manager as defined under the new Alternative Investment Fund Manager's Directive following the implementation of the EU's directive on self-managed investment funds. Following this the Company has retained responsibility for the custody of its investments. YFM Private Equity Limited has continued to provide advisory and administrative services to the Company. I am pleased to report that The City Partnership (UK) Limited has been appointed as Company Secretary to the Company with effect from 1 December 2014.

 

The Company has complied with the new reporting regulations throughout this annual report. The Board hopes these changes will help shareholders gain a greater understanding of the Company's performance and strategy.

 

Changes to Investment Advisory Agreement

Your Board has agreed with YFM Private Equity Limited a number of changes to the Investment Advisory Agreement ("the IAA"). In particular it has added clauses that:

i              With effect from 1 October 2013 limit total deal fees paid by investee companies to the Investment Adviser at the point of investment  to 3.0 per cent of the total sum invested in new unquoted investments during the financial period, and 2.0 per cent of the total sum invested in follow-on unquoted investments during the financial period. Any excess of total fees over these limits will be rebated to the Company; and

 

ii             Limit the annual monitoring and directors fees paid by investee companies to the Investment Adviser to a maximum of £40,000 per annum per unquoted investment.

 

Further details of the IAA are set out in note 3.

 

Subsequent Events

 

Since the end of the reporting period, the Company has completed one additional investment for £0.4 million. At the date of this report the Company has approval for four further investments totalling £3.4 million.

 

Outlook

 

During the year there have been some indicators of improved economic conditions which have continued into the early part of 2015. Consequently 2014 has been a year of strong new investment levels and this momentum has continued into 2015, although we continue to take a cautious approach and look for businesses with resilient growth strategies.  Funds raised under the recent prospectus offer will ensure your Company can continue to take advantage of these opportunities.

 

Good progress continues to be made across the portfolio to position businesses to grow and realise shareholder value.

 

 

Richard Last

Chairman

26 March 2015



Objectives and Key Policies

 

The Company's objective is to provide investors with an attractive long-term tax free dividend yield whilst seeking to maintain the capital value of their investment and the Company's status as a venture capital trust.

 

Investment Policy

The investment strategy of the Company is to create a portfolio with a mix of companies operating in traditional industries and those that offer opportunities in the development and application of innovation.

The legislation governing VCTs requires that at least 70 per cent by value of its holdings must be in qualifying holdings. The maximum value of any single investment is 15 per cent at the time of investment.

The Company invests in UK businesses across a broad range of sectors including, but not limited to, Software, IT & Telecommunications, Business Services, Manufacturing & Industrial Services, Retail & Brands and Healthcare, in VCT qualifying and non-qualifying unquoted and AIM traded securities.

 

The Company invests in a range of securities which may include ordinary and preference shares, and fixed income securities, such as corporate bonds and gilts. Unquoted investments are structured so as to spread risk and enhance revenue yields, usually as a combination of ordinary shares, preference shares and loan stock, while AIM securities are generally held in ordinary shares.

 

Borrowing

The Company funds the investment programmes out of its own resources and has no borrowing facilities for this purpose.

 

Co-Investment

British Smaller Companies VCT plc and British Smaller Companies VCT2 plc ("the VCTs") have in aggregate first choice of all investment opportunities requiring up to £4.5 million of equity. Amounts above £4.5 million may be allocated one third to YFM's institutional co-investment fund and two thirds to the VCTs. Where there are opportunities for the VCTs to co-invest with each other the proposed basis for allocation is 40 per cent to the Company and 60 per cent to British Smaller Companies VCT plc. The Board of the Company has discretion as to whether or not to take up, or in the circumstances where British Smaller Companies VCT plc does not take its allocation, increase its allocation in such co-investment opportunities.

 

Asset Mix

Pending investment in VCT-qualifying and non-VCT qualifying unquoted or AIM traded securities, surplus cash is primarily held in interest bearing instant access, notice and fixed term bank accounts and can also be invested in non-qualifying unquoted investments.

 

Remuneration Policy

The Company's policy on the remuneration of its directors, all of whom being non-executive directors, can be found on page 43 of the annual report.

 

Other Key Policies

Details of the Company's policies on the payment of dividends, the DRIS and  the buy-back of shares are given on page 2 of the annual report.  In addition to these the Company's anti-bribery and environmental and social responsibilities policies can be found on page 32 of the annual report.

 

Practices and Operations

 

The Investment Adviser is responsible for the sourcing and screening of initial enquiries, carrying out suitable due diligence investigations and making submissions to the Board regarding potential investments. Once approved, further due diligence is carried out as necessary and HMRC clearance is obtained for approval as a Qualifying Investment.

 

The Board approves all investment and divestment decisions save in that new investments up to £250,000 in companies whose shares are traded on AIM or a recognised UK Exchange and where the decision is required urgently, in which case the Chairman of the Board of directors, if appropriate, may act in consultation with the Investment Adviser.

 

The Board regularly monitors the performance of the portfolio and the investment requirements set by the relevant VCT legislation. Reports are received from the Investment Adviser regarding the trading and financial position of each investee company and senior members of the Investment Advisory Team regularly attend the Company's Board meetings. Monitoring reports are also received at each Board meeting on compliance with VCT regulations so that the Board can monitor that the venture capital trust status of the Company is maintained and take corrective action if appropriate.

 

The Board reviews the terms of YFM Private Equity Limited's appointment as Investment Adviser on a regular basis.

 

YFM Private Equity Limited has performed investment advisory, administrative and secretarial services for the Company since its inception on 28 November 2000. The principal terms of the agreement under which these services are performed are set out in note 3.

 

Performance Incentive

The Investment Adviser will receive an amount (satisfied by the issue of shares) equivalent to 20 per cent of the amount by which the cumulative dividends paid as at the last Business Day in December in any year plus the middle market quotation per share exceeds 120 pence per share on that same day, multiplied by the number of shares issued and the shares under option (if any). These subscription rights are exercisable in the ratio 95:5 between the Investment Adviser and Chord Capital Limited. Further details are given in note 3.

 

 

In the opinion of the directors the continuing appointment of YFM Private Equity Limited as Investment Adviser is in the interests of the shareholders as a whole in view of its experience in advising venture capital trusts and in making, managing and exiting investments of the kind falling within the Company's investment policies.

 

Key Performance Indicators

 

The Company monitors a number of key performance indicators, which are typical for VCTs, as detailed below:

 

Total Return

The recognised measurement of financial performance in the VCT industry is that of total return (expressed in pence per share) calculated by adding the total cumulative dividend paid to shareholders from the date a company is launched to its current reporting date, inclusive of any tax credits, to the net asset value at that date.  The chart on page 11 of the annual report shows the five year total return of your Company, calculated by reference to the net asset value per ordinary share plus cumulative dividends paid per ordinary share.

 

The evaluation of comparative success of the Company's total return is by way of reference to the share price total return for approximately 60 generalist VCTs as published by The Association of Investment Companies ("the AIC"). This is the Company's stated benchmark index. A comparison and explanation of the calculation of this return is shown in the Directors' Remuneration Report on page 45 of the annual report.

 

Shareholder Returns

The table below shows the cumulative dividends, the total return on each fundraising round per ordinary share and the total return if a shareholder had opted to participate in the Company's DRIS. The cumulative dividend and total return figures in this table exclude the benefits of all tax reliefs while the last two columns include the benefit of tax relief as noted.

 

Tax year

Offer price

Offer price net of initial tax relief

Net asset value as at 31 December 2014

Cumulative dividends paid since fundraising1

Total return since fundraising/date of acquisition

Overall return including tax relief since fundraising without participation in the DRIS2

Overall return including tax relief since fundraising with participation in the DRIS3

All pence per ordinary share








2000/01 and 2001/02

100.00

80.00

62.90

43.50

106.40

126.40

155.44

2001/02 and 2002/03

100.00

80.00

62.90

43.50

106.40

126.40

155.44

December 2005 issue of shares on acquisition of British Smaller Technology Companies4

100.00

80.00

43.19

28.94

72.13

92.13

142.00

2009/10 and 2010/11

77.25

54.08

62.90

21.50

84.40

107.58

119.07

2010/11 and 2011/12

70.25

49.18

62.90

17.50

80.40

101.48

110.26

2011/12

70.50

49.35

62.90

13.50

76.40

97.55

103.78

2012/13 and 2013/14

68.00

47.60

62.90

9.00

71.90

92.30

96.12

2013/14 and 2014/15

68.00

47.60

62.90

4.50

67.40

87.80

89.41

 

Notes

1.     This assumes that at the time of investment the tax relief given on the investment was not also invested in shares of the Company.

2.     NAV plus cash dividends paid plus tax relief on initial subscription.

3.     NAV plus tax relief on the initial subscription plus additional tax relief and NAV on DRIS shares purchased. Assuming that all dividends. since inception were invested under terms of current DRIS.

4.     Assuming initial offer price and initial tax relief from original subscription in British Smaller Technology Companies VCT plc.

 

 

 

 

Expenses

The Board monitors expenses using the Ongoing Charges figure, as calculated in line with the AIC recommended methodology. This figure shows shareholders the annual percentage reduction in net asset value as a result of recurring operational expenses and, whilst based on historical information, provides an indication of the likely level of costs that will be incurred in managing the fund in the future. The Ongoing Charges figure has fallen since 31 December 2013 as the raising of additional capital in the year has spread the fixed costs over a larger asset base.

 


Year to 31 December 2014 (%)

Year to 31 December 2013 (%)

Ongoing Charges figure

2.56

2.83

 

The Ongoing Charges figure replaces the Total Expense Ratio (TER%) previously reported. TER% is calculated as the annual ongoing charges (excluding any performance related fees,  trail commission payable to financial intermediaries, but excluding  VAT) over total net asset value as at the relevant period end and forms the basis of any expenses in excess of the operating costs cap described in note 3 on page 58 of the annual report.  There was no breach of the cap in the current or prior year. Following the final allotment in respect of the current fundraising the costs cap will be reduced from 3.25 per cent to 2.9 per cent.

 

Compliance with VCT Legislative Tests

The main business risk facing the Company is the retention of VCT qualifying status. The Board receives regular reports on compliance with the VCT legislative tests from its Investment Adviser.  In addition the Board receives formal reports from its VCT Status Advisers twice a year. The Board can confirm that during the period all of the VCT legislative tests have been met.  With effect from 1 January 2015 Robertson Hare LLP replaced PricewaterhouseCoopers LLP as VCT Status Adviser to the Company.

 

Under Chapter 3 Part 6 of the Income Tax Act 2007, in addition to the requirement for a VCT's ordinary share capital to be listed in the Official List on a European regulated market  throughout the period, there are a further five specific tests that VCTs must meet following the initial three year provisional period:

 

Income Test

The Company's income in the period must be derived wholly or mainly (70 per cent) from shares or securities. The Company complied with this test in the period, with 89.68 per cent (2013: 72.79 per cent) of income being derived from such sources.

 

Retained Income Test

The Company must not retain more than 15 per cent of its income from shares and securities. The Company complied with this test in the period, with 0 per cent (2013: 0 per cent) of income being retained in the period subject to payment of the final dividend to be approved at the Annual General Meeting on 15 May 2015.

 

Qualifying Holdings Test

At least 70 per cent by value of the Company's investments must be represented throughout the period by shares or securities comprised in qualifying holdings of investee companies. The Company complied with this test, with 77.54 per cent (2013: 85.04 per cent) of value being in qualifying holdings.

 

Eligible Shares Test

At least 30 per cent of the Company's qualifying holdings must be represented throughout the period by holdings of non-preferential ordinary shares. The Company complied with this test, with 39.95 per cent (2013: 46.42 per cent) of value being in holdings of eligible ordinary shares.

 

For monies raised from 6 April 2011 onwards the eligible shares test highlighted above increases to at least 70 per cent of qualifying holdings that must be represented by eligible shares. The Company complied with this test, with 76.92 per cent of value being in holdings of eligible shares.

 

In addition, monies raised from share issues from 6 April 2012 onwards are not permitted to be used to finance buy-outs or otherwise to acquire existing shares. There is also an annual limit for each investee company which provides that they may not raise more than £5.0 million of state aid investment (including from VCTs) in the 12 months ending on the date of each investment.

 

The Board and Investment Adviser are mindful of these additional requirements and of balancing investments to ensure continued compliance.

 

Maximum Single Investment Test

The value of any one investment has, at any time in the period, not represented more than 15 per cent of the Company's total investment value.  This is calculated at the time of investment and further additions and therefore cannot be breached passively. The Company has complied with this test with the highest such value being 5.24 per cent (2013: 6.72 per cent).

 

Other

The Finance Bill 2014 contained conditions/restrictions with respect to the use of monies in respect of VCTs. In particular, no dividends can be paid out of cancelled share premium arising from shares allotted on or after 6 April 2014 until at least three financial years have elapsed. In the case of the Company this is 31 December 2017.

From the share premium cancellation of £13.55 million on 10 October 2014, £12.21 million will be available for distribution following the filing of the annual report and accounts and £1.34 million will remain undistributable until 31 December 2017.

 

 

Investment Review

 

The £13.6 million of investments in the year to 31 December 2014 has significantly increased the scale and diversification of the portfolio.

 

The improving economic outlook and changes in EU restrictions on qualifying VCT investments allowing investments in any 12 month period up to £5.0 million from VCT funds have contributed to an increase in the volume and size of investment opportunities with this trend continuing into 2015.

 

Considerable progress has been made by many of the businesses in the Company's investment portfolio during the year with an overall value gain of £0.98 million excluding movements due to investments and realisations. This has enabled the Company to maintain its strong investor returns and is further analysed below. The proposed final dividend is 2.5 pence per ordinary share. Since the year end one investment for £0.4 million has been completed. A further four investments totalling £3.4 million have been approved at the date of this report.

 

 

Investment portfolio (excluding fixed income securities)

£000

%

Unquoted value gain

368

37.5

Quoted value loss

(257)

(26.2)

Gain on disposal over opening value

560

57.1

Portfolio movement

671

68.4

Gain from deferred proceeds

       310

31.6

Total Value Movement

981

100.0

 

 

At 31 December 2014 the investment portfolio was valued at £28.2 million, representing 71.7 per cent of net assets (53.4 per cent at 31 December 2013).  Cash at 31 December 2014 was £10.6 million representing 27.0 per cent of net assets (43.3 per cent at 31 December 2013, 46.19 per cent including gilt investments).

 

Significant Investment Movements

 

Unquoted

The £0.37 million unrealised valuation gain from the unquoted portfolio is as a result of good progress by a number of businesses which have seen profit growth. The top four value gains in the period all resulted from filing of improved profitability:

 

·     GTK (Holdco) Limited (value gain of £0.45 million) supplier of specialist electronic components;

·     Mangar Health Limited (value gain of £0.44 million) manufacturer of lifting products for care of the elderly;

·     Intelligent Office Limited (value gain of £0.40 million) provider of outsourced business services; and

·     Callstream Group Limited (value gain of £0.27 million) supplier of telephone services to SMEs.

 

 

These gains were partially offset by two businesses which saw profits impacted by short term reductions in public sector defence budgets:

 

·     Seven Technologies Holdings Limited (down £0.79 million) a supplier of remote telecoms surveillance systems: and

·     Deep-Secure Limited (down £0.49 million) supplier of secure communication software to high security government and military departments.

 

 

Quoted

The performance of the quoted portfolio in the period has been mixed resulting in a £0.26 million overall reduction. The two most significant value movements were EKF Diagnostic Holdings plc (a fall of £0.12 million) and Iomart Group plc (a fall of £0.12 million); albeit both have subsequently recovered.



 

New Investments

During the year ended 31 December 2014 the Company completed sixteen investments totalling £13.6 million (excluding capitalised interest and non-cash proceeds received on the sale of investments). This comprised of ten new unquoted and one new quoted  investment and five follow-on investments into existing portfolio companies and is analysed below.

 

New and Follow-On Investments                                                                                                          Investments made £m

 Date

 Company

New

Follow-on

Total

Jan-14

Mangar Health Limited

1.64


1.64

Mar-14

EKF Diagnostics Holdings plc*


0.06

0.06

May-14

Intelligent Office UK Limited (via IO Outsourcing Limited)

1.96


1.96

May-14

EKF Diagnostics Holdings plc*


0.15

0.15

Jun-14

AB Dynamics plc*


0.10

0.10

Jun-14

Intamac Systems Limited

0.75


0.75

Jun-14

Macro Art Holdings Limited

0.84


0.84

Sep-14

Harvey Jones Holdings Limited


0.80

0.80

Sep-14

The Heritage Window Company Holdco Limited

1.27


1.27

Oct-14

Gamma Communications plc*

0.17


0.17

Oct-14

Cambrian Park & Leisure Homes Limited

1.20


1.20

Oct-14

Springboard Research Holdings Limited

1.19


1.19

Nov-14

ACC Aviation (via NewAcc (2014) Limited)

1.38


1.38

Nov-14

Business Collaborator Limited

1.34


1.34

Dec-14

Wakefield Acoustics (via Malvar Engineering Limited)

0.72


0.72

Dec-14

PowerOasis Limited


0.03

0.03


Invested in the 12 months to 31 December 2014

12.46

1.14

13.60

 

*Quoted company

 

The eleven new investments during the year totalled £12.46 million:

 

·     In January 2014 the Company invested £1.64 million to fund the management buyout of Mangar Health Limited, a world leader in inflatable lifting, handling and bathing equipment for the elderly, disabled and emergency services markets.

·     In May 2014 the Company invested £1.96 million to fund the management buyout of Intelligent Office UK Limited, a leading provider of business process outsourcing solutions to the UK legal sector.

·     In June 2014 the Company provided £0.75 million of growth capital funding to Intamac Systems Limited, which develops technology to connect physical products via the internet so they can be monitored and controlled using smart mobile phones and computers.

·     In June 2014 the Company invested £0.84 million to fund the management buyout and growth capital for Macro Art Holdings Limited, a specialist wide-format digital printer.

·     In September 2014 the Company funded the management buyout and provided development capital with an investment of £1.27 million into The Heritage Window Company Holdco Limited, a specialist manufacturer and supplier of slim line aluminium windows.

·     In October 2014 the Company invested £0.17 million as part of an AIM placing to support the expansion of Gamma Communications plc, a leading provider of voice, data and mobile communication services to UK businesses.

·     In October 2014 the Company invested £1.20 million to support the management buyout of Cambrian Park & Leisure Homes Limited, the largest holiday lodge builder in Wales.

·     In October 2014 the Company invested £1.19 million to support the management buyout of Springboard Research Holdings Limited, a leading provider of retail performance monitoring and data services.

·     In November 2014 the Company invested £1.38 million to support the management buyout and future growth plans of ACC Aviation, a specialist broker of leasing and chartering services to international airlines.

·     In November 2014 the Company invested £1.34 million in backing the management buyout of market leading software company Business Collaborator Limited which facilitates collaboration within the construction sector.

·     In December 2014 the Company invested £0.72 million in the management buyout of Wakefield Acoustics, a specialist supplier of industrial acoustic solutions.

 

The majority of the above investments are valued at cost and will  be moved to earnings-based valuations during 2015.

 

The £1.14 million of investments into existing portfolio companies during the year was dominated by £0.80 million invested into kitchen manufacturer and retailer Harvey Jones Holdings Limited in the form of a high-yielding debt instrument.

  

 

Disposal of Investments

 

During the year to 31 December 2014 the Company received proceeds from disposals, repayments of loans and deferred consideration of £2.74 million, and  £1.37 million from the disposal of fixed income securities. Overall this resulted in a value gain on disposal of investments of £0.87 million compared to 31 December 2013 valuations and a realised gain on cost of £1.71 million.  This is analysed below.

 

Disposal of Investments

Net proceeds from sales of investments

£000

Cost of investments

 

 

£000

Opening value 31 December 2013

£000

 

Gain on opening value

 

£000

Gain on cost

 

 

£000

Sale of portfolio investments

2,314

1,036

1,754

560

1,278

Deferred proceeds received

345

-

120

225

345

Deferred proceeds accrued

85

-

-

85

85

Investment portfolio disposals

2,744

1,036

1,874

870

1,708

Fixed income securities disposals

1,365

1,363

1,365

-

2

Total investment and fixed income securities disposals

4,109

2,399

3,239

870

1,710

 

The most significant proceeds related to:

 

·    In December 2014 the Company realised its investment in leading independent contract caterer Waterfall Sevices Limited via a secondary buyout backed by LDC. Proceeds from the sale in December were £0.96 million, a profit on the 31 December 2013 carrying value of £0.48 million and a profit on cost of £0.94 million.

·    £0.35 million of additional deferred proceeds was received from Beckton Dickinson relating to the trade sale of Sirigen Group Limited in 2012, following successful delivery of the two year development milestones. This brings the total proceeds to date to £1.88 million and increases the cash return to 3.6x.

·    During the year the Company sold various shares in quoted holdings. The non-core holdings in Vianet Group plc and Optos plc were realised for £0.33 million in line with the opening 31 December 2013 value. Holdings in Pressure Technologies plc and Iomart Group plc were also partially realised for combined proceeds of £0.30 million, realising a gain on their opening carrying value of £0.06 million.

·    Several unquoted investments repaid loan balances totalling £0.72 million following strong cash generation, resulting in a small realised profit on carrying value due to redemption premium. This included DisplayPlan Holdings Limited (£0.23 million), GTK (Holdco) Limited (£0.23 million), Callstream Group Limited (£0.17 million), Bagel Nash Group Limited (£0.08 million) and Macro Art Holdings Limited (£0.02 million).

 

A further analysis of all investments sold in the year can be found in note 7 to the financial statements on page 63 of the annual report.

 

Portfolio Composition

As at 31 December 2014 the portfolio of quoted and unquoted investments had a value of £28.2 million of which the unquoted investments constitute 92 per cent of the value and the quoted investments 8 per cent of the value.  An analysis of the movements in the year is shown on page 21 of the annual report.

 

This year we have continued to improve the diversification of the portfolio. This is probably shown most clearly by the fact that at 31 December 2014 there were 21 investments with a value greater than £0.5 million which compares to 11 a year earlier. Investment company information is shown on pages 22 to 29 of the annual report.

 

The charts on page 14 of the annual report show the composition of the portfolio as at 31 December 2014 by industry sector, age of investment, asset class and the stage of financing at the point of investment.  This demonstrates representation across a wide range of industry sectors.

 

Valuation Policy

Unquoted investments are valued in accordance with the valuation policy set out on page 55 of the annual report, which takes account of current industry guidelines for the valuation of venture capital portfolios. Adjustments to fair value are made where an investment is significantly under-performing. As at 31 December 2014 the percentage of investments falling into each valuation category is shown in the table below:

 


Valuation

£000

% of portfolio by value

Earnings multiple

16,604

59%

Cost, reviewed for change in fair value

7,843

28%

Price of recent investment reviewed for change in fair value

1,641

5%

Quoted investments at bid price

2,128

8%

Total

28,216

100%

 

 

 

Summary and Outlook

 

Some clearer signs of economic recovery have been seen during the year but there remains some uncertainty in global markets. Many of the portfolio companies have delivered improved results, focusing on proven brands, niche growth sectors or rolling out new technology. We will maintain a cautious approach to new investments; only backing proven business models with a clear strategy for value growth.

 

We have seen a marked increase in new investment levels in 2014. This is in part due to changes in EU restrictions on qualifying VCT investments and we expect to see this investment level continue in 2015.

 

We believe that the increasing level of investment, combined with several good exit prospects over the next few years, affords the Board the opportunity to achieve its aim of  increasing dividends  whilst preserving and enhancing the underlying net asset value. The increasing diversification of the portfolio should also help to reduce volatility of returns.



 

Investment Portfolio Summary to 31 December 2014


 

 



Date of initial investment

Location

Industry sector

Current cost

Proceeds to date*

Valuation at 31 December 2014

Realised and unrealised return to date


Current investments




£000

£000

£000

£000


Unquoted portfolio









Intelligent Office (via IO Outsourcing Limited)

May-14

Alloa

Business Services

        1,956

                  -  

                 2,355

          2,355


DisplayPlan Holdings Limited

Jan-12

Baldock

Business Services

            525

            228

                 2,008

          2,236


Mangar Health Limited

Jan-14

Powys

Healthcare

        1,640

                  -  

                 2,081

          2,081


Gill Marine Holdings Limited

Sep-13

Nottingham

Retail & Brands

        1,870

                  -  

                 1,732

          1,732


Seven Technologies Holdings Limited

Apr-12

Belfast

Software, IT & Telecomms

        1,238

            762

                      924

          1,686


GTK (Holdco) Limited

Oct-13

Basingstoke

Manufacturing & Industrial Services

            916

            234

                 1,365

          1,599


ACC Aviation (via Newacc (2014) Limited)

Nov-14

Reigate

Business Services

        1,379

                  -  

                 1,379

          1,379


Business Collaborator Limited

Nov-14

Reading

Business Services

        1,340

                  -  

                 1,340

          1,340


The Heritage Window Company Holdco Limited

Sep-14

Sevenoaks

Manufacturing & Industrial Services

        1,268

                  -  

                 1,268

          1,268


Cambrian Park & Leisure Homes Limited (via DWFCO 8 Limited)

Oct-14

Gwynedd

Manufacturing & Industrial Services

        1,200

                  -  

                 1,200

          1,200


Harvey Jones Holdings Limited

May-07

London

Retail & Brands

        1,193

                  -  

                 1,194

          1,194


Springboard Research Holdings Limited

Oct-14

Bedfordshire

Business Services

        1,186

                  -  

                 1,186

          1,186


Leengate Holdings Limited

Dec-13

Derbyshire

Manufacturing & Industrial Services

            934

                  -  

                 1,080

          1,080


Callstream Group Limited

Sep-10

Henley-in -Arden

Software, IT & Telecomms

            329

            265

                      773

          1,038


Immunobiology Limited

Jun-03

Cambridge

Healthcare

        1,932

                  -  

                      987

               987


Macro Art Holdings Limited

Jun-14

Cambridgeshire

Business Services

            819

               21

                      847

               868


RMS Group Holdings Limited

Jul-07

Goole

Manufacturing & Industrial Services

               70

            349

                      405

               754


Intamac Systems Limited

Jun-14

Northampton

Software, IT & Telecomms

            750

                  -  

                      750

               750


Wakefield Acoustics (via Malvar Engineering Limited)

Dec-14

Cleckheaton

Business Services

            720

                  -  

                      720

               720


Bagel Nash Group Limited

Jul-11

Leeds

Retail & Brands/ Manufacturing & Industrial Services

            732

               93

                      590

               683


PowerOasis Limited

Nov-11

Swindon

Software, IT & Telecomms

            594

                  -  

                      594

               594


Insider Technologies (Holdings) Limited

Aug-12

Manchester

Software, IT & Telecomms

            780

                  -  

                      522

               522


Deep-Secure Limited

Dec-09

Malvern

Software, IT & Telecomms

            500

                  -  

                      424

               424


Selima Holding Company Ltd

Mar-12

Sheffield

Software, IT & Telecomms

            300

                  -  

                      304

               304


Other




        422

                  -  

                           60  

                   60  


Total unquoted investments




     24,593

        1,952

              26,088

       28,040











Quoted portfolio









Pressure Technologies plc

Jun-07

Sheffield

Manufacturing & Industrial Services

            120

            498

                      289

               787


Iomart Group plc

May-11

London

Software, IT & Telecomms

            119

            209

                      231

               440


AB Dynamics plc

May-13

Bradford-on-Avon

Manufacturing & Industrial Services

            253

                  -  

                      364

               364


Brady plc

Dec-10

Cambridge

Software, IT & Telecomms

            134

            163

                      178

               341


EKF Diagnostics Holdings plc

Jun-11

London

Healthcare

            437

                  -  

                      340

               340


Hargreaves Services plc

Aug-12

Durham

Manufacturing & Industrial Services

            325

                  -  

                      262

               262


Gamma Communications plc

Oct-14

Reading

Software, IT & Telecomms

            168

                  -  

                      213

               213


Cambridge Cognition Holdings plc

May-02

Cambridge

Healthcare

            240

                  -  

                      141

               141


Allergy Therapeutics plc

Oct-04

Worthing

Healthcare

            350

                  -  

                      110

               110











Total quoted investments




        2,146

            870

                 2,128

          2,998















     26,739

        2,822

              28,216

       31,038


Full disposals to date




     16,060

     22,323

                           -  

       22,323











Total investment portfolio




     42,799

     25,145

              28,216

       53,361

 

 

 

*Proceeds include premiums and profits on loan repayments and preference redemptions

 

 


Disposal History to 31 December 2014

Name of Company

Date of initial investment

Date of disposal or full provision

Industry sector

Cost

Proceeds to date

Capital return multiple

Gains (losses) on disposal





£000

£000

x

£000

Cozart plc

Jul-04

Oct-07

Healthcare

             1,566

             2,978

                     1.90

                 1,412

Sarian Systems Limited*

Dec-05

Apr-08

Telecoms

                  928

             2,605

                     2.81

                 1,677

DxS Limited

Apr-04

Sep-09

Healthcare

                  163

             2,514

                  15.42

                 2,351

Vibration Technology Limited**

Mar-02

Sep-06

Industrial

             1,061

             2,328

                     2.19

                 1,267

Primal Pictures Limited*

Dec-05

Aug-12

Medical instruments

                  961

             2,256

                     2.35

                 1,295

Sirigen Group Limited

Jun-10

Aug-12

Medical Technology

                  517

             1,876

                     3.63

                 1,359

Amino Technologies plc**

Sep-01

Nov-04

Electronics

                  415

             1,872

                     4.51

                 1,457

Waterfall Services Limited

Feb-07

Dec-14

Business Services

                  483

             1,422

                     2.94

                      939

Digital Healthcare Limited

Jun-05

Aug-13

Medical instruments

             3,072

             1,285

                     0.42

               (1,787)

The ART Technology Group Inc**

Apr-03

Oct-09

Software

                  275

                 638

                     2.32

                      363

Tamesis Limited**

Jul-01

Sep-07

Software

                  150

                 317

                     2.11

                      167

Optos plc*

Dec-05

Jan-14

Healthcare

                  152

                 316

                     2.08

                      164

Tekton Group Limited

Dec-05

Dec-06

Software

                  103

                 296

                     2.87

                      193

Tikit Group plc

May-11

Jan-13

Software

                  198

                 283

                     1.43

                         85

Oxonica plc**

May-02

Sep-09

Chemical

                  241

                 258

                     1.07

                         17

Group NBT plc

May-11

Nov-11

IT Support

                  197

                 256

                     1.30

                         59

Vianet Group plc

Oct-06

Sep-14

Business Services

                  243

                 176

                     0.72

                     (67)

Patsystems plc

Sep-07

Jan-12

Software

                  317

                 164

                     0.52

                   (153)

May Gurney Integrated Services plc

May-11

Mar-13

Construction

                  211

                 141

                     0.67

                      (70)

Arakis Limited

Mar-04

Aug-05

Healthcare

                     14

                 108

                     7.71

                         94

SoseiCo Limited

Aug-05

Feb-06

Healthcare

                  158

                    94

                     0.59

                      (64)

Voxar Limited*

Dec-05

Nov-06

Software

                       -  

                    91

                            -  

                         91

Sirus Pharmaceuticals Limited**

Sep-01

Mar-04

Healthcare

                  270

                    18

                     0.07

                    (252)

Broadreach Networks Limited**

Feb-03

Dec-05

Telecoms

                  550

                    17

                     0.03

                    (533)

Focus Solutions Group plc*

Dec-05

Feb-06

Software

                        7

                       7

                     1.00

                           -  

Oxis Energy Limited*

Dec-05

Dec-12

Electronics

                        5

                       4

                     0.80

                       (  1 )

2 Ergo Group plc

May-11

Jun-13

Software

                  197

                       3

                     0.02

                    (194)

Ellfin Home Care Limited

Dec-07

Dec-13

Healthcare

317

-

-

(317)

Infinite Data Storage Limited**

Mar-02

Dec-07

Software

                  425

                       -  

                            -  

                   (425)

Purely Proteins Limited**

Nov-03

Dec-06

Software

                  438

                       -  

                            -  

                   (438)

ExpressOn Biosystems Limited**

Oct-02

Dec-05

Healthcare

                  450

                       -  

                            -  

                   (450)

Comvurgent Limited*

Dec-05

Dec-07

Software

                  611

                       -  

                            -  

                    (611)

Silistix  Limited**

Dec-03

Dec-10

Electronics

                  1,365

                       -  

                            -  

                    (1,365)

Total




          16,060

          22,323

                            -  

                 6,263

*             Investment acquired solely from the merger with British Smaller Technology Companies VCT plc in December 2005

**            Investment made prior to 31 December 2003

 

Reconciliation of Investment Portfolio Movement since 31 December 2013

 

 

Name of Company

Investment Valuation at 31 December 2013

Disposal Proceeds

Additions

Valuation gains including profits/(losses) on disposal

Investment Valuation at 31 December 2014


£000

£000

£000

£000

£000







Intelligent Office (via IO Outsourcing Limited)

-

-

1,956

399

2,355

Mangar Health Limited

-

-

1,640

441

2,081

DisplayPlan Holdings Limited

2,142

(228)

-

94

2,008

Gill Marine Holdings Limited

1,870

-

-

(138)

1,732

ACC Aviation (via Newacc (2014) Limited)

-

-

1,379

-

1,379

GTK (Holdco) Limited

1,141

(225)

-

449

1,365

Business Collaborator Limited

-

-

1,340

-

1,340

The Heritage Window Company Holdco Limited

-

-

1,268

-

1,268

Cambrian Park & Leisure Homes Limited

-

-

1,200

-

1,200

Harvey Jones Holdings Limited

441

-

804

(51)

1,194

Springboard Research Holdings Limited

-

-

1,186

-

1,186

Leengate Holdings Limited

934

-

-

146

1,080

Immunobiology Limited

987

-

-

-

987

Seven Technologies Holdings Limited

1,711

-

-

(787)

924

Macro Art Holdings Limited

-

(21)

840

28

847

Callstream Group Limited

674

(169)

-

268

773

Intamac Systems Limited

-

-

750

-

750

Wakefield Acoustics (via Malvar Engineering Limited)

-

-

720

-

720

PowerOasis Limited

425

-

27

142

594

Bagel Nash Group Limited

733

(80)

8

(71)

590

Insider Technologies (Holdings) Limited

689

-

-

(167)

522

Deep-Secure Limited

915

-

-

(491)

424

Waterfall Services Limited

489

(964)

-

475

-







Other Investments

3,104

(627)

486

(66)

2,897







Total Movement

16,255

(2,314)

13,604

671

28,216


 

 

 

Risk Factors

 

The Board carries out a regular review of the risk environment in which the Company operates. The principal risks and uncertainties identified by the Board and techniques used to mitigate these risks are as follows:

 

The Board seeks to mitigate its principal risks by setting policy, regularly reviewing performance and monitoring progress and compliance. In the mitigation and management of these risks, the Board applies rigorously the principles detailed in section C.2:"Risk Management & Internal Control" of The UK Corporate Governance Code issued by the Financial Reporting Council in September 2012. Details of the Company's internal controls are contained in the Corporate Governance and Internal Control sections on page 41  of the annual report and further information on exposure to risks including those associated with financial instruments is given in note 17a on page 70 of the annual report.

Loss of Approval as a VCT

Risk - The Company must comply with Chapter 3 Part 6 of the Income Tax Act 2007 which allows it to be exempted from corporation tax on capital gains. Any breach of these rules may lead to the Company losing its approval as a VCT, qualifying shareholders who have not held their shares for the designated holding period having to repay the income tax relief they obtained and future dividends paid by the Company becoming subject to tax. The Company would also lose its exemption from corporation tax on capital gains.

 

Mitigation - One of the Key Performance Indicators monitored by the Company is the compliance with legislative tests. Details of how the Company manages these requirements can be found under the heading "Compliance with VCT Legislative Tests" on pages 12 and 13 of the annual report.

 

Economic

Risk - Events such as recession and interest rate fluctuations could affect investee companies' performance and valuations.

 

Mitigation - As well as the response to 'Investment and Strategic' risk below the Company has a clear investment policy (summarised on page 9 of the annual report) and a diversified portfolio operating in a range of sectors. The Investment Adviser actively monitors investee performance which provides quality information for the monthly review of the portfolio.

 

Investment and Strategic

Risk - Inappropriate strategy, poor asset allocation or consistently weak stock allocation may lead to under performance and poor returns to shareholders. The quality of enquiries, investments, investee company management teams and monitoring, and the risk of not identifying investee under performance might also lead to under performance and poor returns to shareholders.

 

Mitigation - The Board reviews strategy annually.  At each of the Board meetings the directors review the appropriateness of the Company's objectives and stated strategy in response to changes in the operating environment and peer group activity. The Investment Adviser carries out due diligence on potential investee companies and their management teams and utilises external reports where appropriate to assess the viability of investee businesses before investing. Wherever possible a non-executive director will be appointed to the board of the investee.

 

Regulatory

Risk - The Company is required to comply with the Companies Act 2006, the rules of the UK Listing Authority, the Prospectus Rules made by the Financial Conduct Authority and International Financial Reporting Standards as adopted by the European Union and is subject to the EU's Alternative Investment Fund Manager's Directive which took effect from 22 July 2014. Breach of any of these might lead to suspension of the Company's Stock Exchange listing, financial penalties or a qualified audit report.

 

Mitigation - The Investment Adviser and the Company Secretary have procedures in place to ensure recurring Listing Rules requirements are met and actively consults with brokers, solicitors and external compliance advisers as appropriate. The key controls around  regulatory compliance are explained on page 41 of the annual report.

 

Reputational

Risk- Inadequate or failed controls might result in breaches of regulations or loss of shareholder trust.

 

Mitigation - The Board is comprised of directors with suitable experience and qualifications who report annually to the shareholders on their independence. The Investment Adviser is well-respected with a proven track record and has a formal recruitment process to employ experienced investment staff. Allocation rules relating to co-investments with other funds advised by the Investment Adviser, have been agreed between the Investment Adviser and the Company.  Advice is sought from external advisors where required. Both the Company and the Investment Adviser maintain appropriate insurances.

 

Operational 

Risk - Failure of the Investment Adviser's and administrator's accounting systems or disruption to its business might lead to an inability to provide accurate reporting and monitoring.

 

Mitigation - The Investment Adviser has a documented disaster recovery plan.

 

Financial

Risk - Inadequate controls might lead to misappropriation of assets. Inappropriate accounting policies might lead to misreporting or breaches of regulations.

 

Mitigation - The key controls around financial reporting are described on page 41 of the annual report.

 

Market/Liquidity

Risk - Lack of liquidity in both the venture capital and public markets. Investment in AIM quoted and unquoted companies, by their nature, involve a higher degree of risk than investment in companies trading on the main market. In particular, smaller companies often have limited product lines, markets or financial resources and may be dependent for their management on a smaller number of key individuals. The fact that a share is traded on AIM does not guarantee its liquidity. The spread between the buying and selling price of such shares may be wide and thus the price used for valuation may not be achievable. In addition, the market for stock in smaller companies is often less liquid than that for stock in larger companies, bringing with it potential difficulties in acquiring, valuing and disposing of such stock.

 

Mitigation - Overall liquidity risks are monitored on an ongoing basis by the Investment Adviser and on a quarterly basis by the Board. Sufficient investments in cash and fixed income securities are maintained to pay expenses as they fall due.

 

 

Other Matters

 

The Board recognises the requirement under Section 414C of the Companies Act 2006 to detail information about environmental matters (including the impact of the Company's business on the environment), employee, human rights, social and community issues, including information about any policies it has in relation to these matters and effectiveness of these policies.

 

The Company seeks to ensure that its business is conducted in a manner that is responsible to the environment. The management and administration of the Company is undertaken by the Investment Adviser. YFM Private Equity Limited recognises the importance of its environmental responsibilities, monitors its impact on the environment and implements policies to reduce any damage that might be caused by its activities.  Initiatives of the Investment Adviser designed to minimise its and the Company's impact on the environment include recycling and reducing energy consumption. Given the size and nature of the Company's activities and the fact that it has no employees, the Board considers there is limited scope to develop and implement social and community policies.

 

Anti-Bribery and Corruption Policy

The Company has a zero tolerance approach to bribery. The following is a summary of its policy:

·      it is the Company's policy to conduct all of its business in an honest and ethical manner. The Company is committed to acting professionally, fairly and with integrity in all its business dealings and relationships;

·      the directors of the Company, the Investment Adviser and any other service providers must not promise, offer, give, request, agree to receive or accept financial or other advantage in return for favourable treatment, to influence a business outcome or gain any business advantage on behalf of the Company or encourage others to do so; and

·      the Company has communicated its anti-bribery policy to the Investment Adviser and its other service providers.

 

The Company had no employees during the year. The Board is composed of three male non-executive directors. For a review of the policies used when appointing directors to the Board of the Company please refer to the Directors' Remuneration Report in the annual report.

 

  

 

 

Directors' Responsibilities Statement.

 

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare the financial statements for each financial year. Under that law the directors are required to prepare the financial statements and have elected to prepare the Company's financial statements in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss for the Company for that period.

 

In preparing these financial statements, the directors are required to:

 

·     select suitable accounting policies and then apply them consistently;

·     make judgements and accounting estimates that are reasonable and prudent;

·     state whether they have been prepared in accordance with IFRSs as adopted by the European Union, subject to any material departures disclosed and explained in the financial statements; and

·     prepare a Strategic Report, Directors' Report and Directors' Remuneration Report which comply with the requirements of the Companies Act 2006.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that its financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Website Publication

The directors are responsible for ensuring the annual report and the financial statements are made available on a website. Financial statements are published on the Company's website at www.bscfunds.com in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the Company's website is the responsibility of the directors. The directors' responsibility also extends to the ongoing integrity of the financial statements contained therein.

 

Directors' Responsibilities pursuant to DTR4

The directors confirm to the best of their knowledge:

 

·     the financial statements have been prepared in accordance with IFRSs as adopted by the European Union and give a true and fair view of the assets, liabilities, financial position and profit and loss of the Company; and

·     the annual report includes a fair review of the development and performance of the business and the financial position of the Company, together with a description of the principal risks and uncertainties that it faces.

 

Having taken advice from the Audit Committee the Board considers the annual report and accounts, taken as a whole, are fair, balanced and understandable and that it provides the information necessary for shareholders to assess the Company's performance, business model and strategy.

 

The names and functions of all the directors are stated on page 33 of the annual report.

 

For and on behalf of the Board.

 

This statement was approved by the Board and signed on its behalf on 26 March 2015.

 

Richard Last

Chairman


Financial Statements

 

Statement of Comprehensive Income for the year ended 31 December 2014

                                                                                                                                                                    



2014

2013


 

Notes

 

Revenue

£000

 

Capital

£000

 

Total

£000

 

Revenue

£000

 

Capital

£000

 

Total

£000









Gain on disposal of investments


-

870

870

-

596

596

Gains on investments held at fair value


-

111

111

-

1,748

1,748

Income

2

1,272

-

1,272

689

-

689

Administrative expenses:








     Investment Adviser's fee


(173)

(521)

(694)

(141)

(421)

(562)

     Other expenses


(402)

-

(402)

(340)

-

(340)



(575)

(521)

(1,096)

(481)

(421)

(902)









Profit before taxation


697

460

1,157

208

1,923

2,131









 Taxation

4

(7)

7

-

-

-

-









Profit for the year

 


690

467

1,157

208

1,923

2,131

Total comprehensive income for the year

 


690

467

1,157

208

1,923

    2,131

Basic and diluted earnings per ordinary share

 

6

1.19p

0.81p

2.00p

0.46p

4.27p

4.73p









 

The Total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards ('IFRSs') as adopted by the European Union.  The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('SORP') 2009 published by The AIC.

 


Balance Sheet At 31 December 2014

 



 

 

 


 

 

 

2014

 

 

 

2013

Assets



Notes

£000

£000







Non-current assets






Investments



7

28,216

16,255

Fixed income securities



7

-

890

Financial assets at fair value through profit or loss



7

28,216

17,145

Trade and other receivables




417

132





28,633

17,277







Current assets






Trade and other receivables




314

123

Cash on fixed term deposit




-

4,500

Cash and cash equivalents




10,633

8,680





10,947

13,303

Liabilities












Current liabilities






Trade and other payables




(247)

(122)

Net current assets




10,700

13,181

 

Net assets




 

39,333

 

30,458



















Shareholders' equity






Share capital




6,447

4,822

Share premium account




342

4,926

Capital redemption reserve




88

88

Other reserve




2

2

Merger reserve




5,525

5,525

Capital reserve




24,822

14,568

Investment holding gains and losses




1,507

         448    

Revenue reserve




600

79







Total shareholders' equity


 

 


39,333

30,458

 

Net asset value per ordinary share

 



 

8

 

62.9p

 

65.6p







 

 



Statement of Changes in Equity for the year ended 31 December 2014

 


 

 

 

 

 

 

Share capital

 

Share premium account

 

 

 Other reserves1

 

 

Merger reserve

 

 

Capital reserve

 

 

Investment holding  gains

 (losses)

 

 

Revenue reserve

 

 

 

Total

equity


£000

£000

 

£000

£000

£000

£000

£000

£000

Balance at 31 December 2012

4,271

14,806

90

5,525

7,225

(4,919)

154

27,152

Revenue return for the year

-

-

-

-

-

-

208

208

Capital expenses

-

-

-

-

(421)

-

-

(421)

Investment holding gain on investments held at fair value

 

-

 

-

 

-

 

-

 

-

 

1,748

 

-

 

     1,748

Realisation of investments in the year

 

-

 

-

 

-

 

-

 

596

 

-

 

-

 

596

Total comprehensive income for the year

 

-

 

-

 

-

 

-

175

1,748

208

2,131

Issue of share capital

504

2,964

-

-

-

-

-

3,468

Issue costs2

-

(178)

-

-

-

-

-

(178)

Purchase of own shares

-

-

-

-

(309)

-

-

(309)

Issue of shares - DRIS

47

239

-

-

-

-

-

286

Dividends

-

-

-

-

(1,800)

-

(283)

(2,083)

Cancellation of share premium account - net of costs

 

-

 

(12,905)

 

-

 

-

 

12,896

 

-

 

-

 

(9)

Total transactions with owners

551

(9,880)

-

-

10,787

-

(283)

1,175

Realisation of negative goodwill

 

-

 

-

 

-

 

-

 

177

 

(177)

 

-

 

-

Realisation of prior year investment holding gains

 

-

 

-

 

-

 

-

 

(3,796)

 

3,796

 

-

 

-

Balance at 31 December 2013

4,822

4,926

90

5,525

14,568

448

79

30,458

Revenue return for the year

-

-

-

-

-

-

690

690

Capital expenses

-

-

-

-

(514)

-

-

(514)

Investment holding gain on investments held at fair value

 

-

 

-

 

-

 

-

 

-

 

111

 

-

 

         111

Realisation of investments in the year

 

-

 

-

 

-

 

-

 

870

 

-

 

-

 

870

Total comprehensive income  for the year

 

-

 

-

 

-

 

-

356

111

690

1,157

Issue of share capital

1,551

9,200

-

-

-

-

-

10,751

Issue costs2


(591)

-

-

-

-

-

(591)

Purchase of own shares

-

-

-

-

(75)

-

-

(75)

Issue of shares - DRIS

74

362

-

-

-

-

-

436

Dividends

-

-

-

-

(2,625)

-

(169)

(2,794)

Cancellation of share premium account - net of costs

-

(13,555)

-

-

13,546

-

-

(9)

Total transactions with owners

1,625

(4,584)

-

-

10,846

-

(169)

7,718

Realisation of negative goodwill

 

-

 

-

 

-

 

-

 

13

 

(13)

 

-

 

-

Realisation of prior year investment holding gains

 

-

 

-

 

-

 

-

 

(961)

 

961

 

-

 

-

Balance at 31 December 2014

6,447

342

90

5,525

24,822

1,507

600

39,333

 










 

 

 

  

 

 

Reserves as above

6,447

342

90

5,525

24,822

1,507

600

39,333

Less undistributable reserves

(6,447)

(342)

(90)

(5,525)

(1,343)

(1,507)

-

(15,254)

Less interest not yet distributable

 

-

 

-

 

-

 

-

 

-

 

-

 

(332)

 

(332)

Less deferred proceeds

-

-

-

-

(85)

-

-

(85)

Reserves available for distribution3

-

-

-

-

23,394

-

268

23,622

 

 

 

 

1             Other reserves include the capital redemption reserve and other reserve, which are non-distributable.  The other reserve was created upon the exercise of warrants and the capital redemption reserve was created for the purchase and cancellation of own shares.

 

2             Issue costs include both fundraising costs and costs incurred from the Company's DRIS.

 

3             Subject to filing these financial statements at Companies House.

 

The merger reserve was created to account for the difference between the nominal and fair value of shares issued as consideration for the acquisition of the assets and liabilities of British Smaller Technology Companies VCT plc. The reserve was created after meeting the criteria under section 131 of the Companies Act 1985 and the provisions of the Companies Act 2006 for merger relief.  The merger reserve is a non-distributable reserve.

 

The capital reserve and revenue reserve are both primarily distributable reserves. The reserves total £25,422,000 (2013: £14,647,000) representing an increase of £10,775,000 (2013: £7,268,000 increase) during the year. This change arises from the profit in the year of £1,046,000 (2013: £383,000), a transfer of valuation losses from the investment holding reserve of £961,000 (2013: £3,796,000), dividends of £2,794,000 (2013: £2,083,000), purchase of shares of £75,000 (2013: £309,000), realisation of negative goodwill of £13,000 (2013: £177,000) and the cancellation of the Company's share premium account of £13,546,000 (2013: £12,896,000). An analysis of the distributable elements of these reserves is given above. The directors also take into account the level of the investment holding gains (losses) reserve and the future requirements of the Company when determining the level of dividend payments.


Statement of Cash Flows for the year ended 31 December 2014


 

 


 

2014

£000

 

2013

£000






Net cash outflow from operating activities



(293)

(79)






Cash flows (used in) from investing activities





Purchase of financial assets at fair value through profit or loss



(14,071)

(5,499)

Proceeds from sale of financial assets at fair value through profit or loss



3,679

2,926

Deferred consideration



345

125

Cash placed on fixed term deposit



-

(4,500)

Cash maturing from fixed term deposits



4,500

7,048

Net cash (outflow) inflow from investing activities

 



(5,547)         

100         






Cash flows from (used in) financing activities





Issue of ordinary shares



10,510

3,412

Costs of ordinary share issues*



(350)

(122)

Purchase of own ordinary shares



(75)

(309)

Dividends paid - net of dividends re-invested



(2,283)

(1,797)

Share premium cancellation cost



(9)

(9)

Net cash inflow from financing activities

 



7,793

1,175






Net increase in cash and cash equivalents



1,953

1,196

Cash and cash equivalents at the beginning of the year



8,680

7,484






Cash and cash equivalents at the end of the year

 



10,633

8,680






* Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

Reconciliation of Profit before Taxation to Net Cash Outflow from Operating Activities

 









2014

£000

2013

£000






Profit before taxation



1,157

2,131

Increase (decrease) in trade and other payables



50

(154)

(Increase) decrease in trade and other receivables


(511)

300

Gains on disposal of investments in the year



(870)

(596)

Profit on investments held at fair value



(111)

(1,748)

Capitalised interest



(8)

(12)

Net cash outflow from operating activities



(293)

(79)







Notes to the Financial Statements for the year ended 31 December 2014

 

1             Basis of Preparation

 

This announcement of the annual results of the Company for the year ended 31 December 2014  has been prepared using accounting policies consistent with those adopted in the full audited financial statements which have been prepared on a going concern basis and in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union and those parts of the Companies Act 2006 applicable to companies reporting under IFRS.  

 

The financial statements have been prepared under the historical cost basis as modified by the measurement of investments at fair value through profit or loss.

 

The accounts have been prepared in compliance with the recommendations set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the AIC  in January 2009 (SORP) to the extent that they do not conflict with IFRSs as adopted by the European Union.

 

The financial statements are prepared in accordance with IFRSs and interpretations in force at the reporting date. The standards and interpretations applicable for the first time that have been adopted are IFRS 10, 11, and 12,  and amendments to IAS 27, 28, 32 and 36. There has been no material impact on the financial statements.

Other standards and interpretations have been issued which will be effective for future reporting periods but have not been adopted early in these financial statements. These include amendments to  IFRS 9, 10, 11, 14 and 15, and amendments to IAS 16, 27, 28 and 38, together with the SORP issued in November 2014. A full impact assessment has not yet been completed in order to assess whether these new standards will have a material impact on the financial statements.

 

 

2             Income


 

 

 


2014

£000

2013

£000






  Dividends from unquoted companies



43

40

  Dividends from AIM quoted companies



160

44






 Interest on loans to unquoted companies



926

384

 Fixed income Government securities



7

18






Income from investments held at fair value through profit or loss



1,136

486

Interest on bank deposits



136

203




1,272

689

 

The above is stated net of £46,000 (2013: £57,000) of income in relation to loan interest, which has been fully provided.

 

3              Administrative expenses

 

 


 

 

 



2014

£000

2013

£000

 

Investment Adviser's fee

694

562



Other expenses:






 

Trail Commission


100

62


 

Directors' remuneration (comprises only short term benefits including social security contributions)


75

75

                           

 

   Administration fee

60

58

 

   Printing

47

29

 

Listing and registrar fees

43

37

 

General expenses

39

40

 

Irrecoverable VAT

20

22

 

Auditor's remuneration - audit fees (excluding irrecoverable VAT)

18

17

 







 





1,096

902

 

 

 

No fees are payable to the auditor in respect of other services supplied pursuant to legislation (2013: £nil).

 

 

YFM Private Equity Limited  has acted as Investment Adviser and performed administrative and secretarial duties for the Company under an agreement dated 28 November 2000, superseded by an agreement dated 31 October 2005 and as varied by agreements dated 8 December 2010, 26 October 2011, 16 November 2012 and 17 October 2014 (the "IAA"). The IAA may be terminated by not less than twelve months' notice given by either party at any time. Following the Financial Conduct Authority's registration of the Company as a Small Registered Alternative Investment Fund Manager, the Company has retained responsibility for the custody of its investments.

The key features of the agreement are:

·      YFM Private Equity Limited receives an Investment Adviser fee, payable quarterly in advance, at the rate of 2.5 per cent of net assets, calculated at half-yearly intervals as at 30 June and 31 December.  The fee is allocated between capital and revenue as described in note 1 on pages 54 to 57 of the annual report;

·      Pursuant to a deed of variation dated 26 October 2011 the advisory fee will be reduced to 1.25 per cent per annum in respect of any net asset value of the Company in excess of £16 million and up to £26.667 million and to 2.0 per cent in respect of any net asset value of the Company in excess of £26.667 million;

·      Pursuant to the deed of variation dated 17 October 2014, YFM Private Equity Limited shall bear the annual operating costs of the Company (including the advisory fee set out above but excluding any payment of the performance incentive fee, details of which are set out below and excluding VAT and trail commissions) to the extent that those costs exceed 2.9 per cent of the net asset value of the Company, a reduction from the previous level of 3.25 per cent; and

·      Under the IAA YFM Private Equity Limited also provides administrative and secretarial services to the Company for a fee of £46,000 per annum plus annual adjustments to reflect movements in the Retail Prices Index.  This fee is charged fully to revenue. 

When the Company makes investments into its unquoted portfolio the Investment Adviser charges that investee an arrangement fee, calculated by applying a percentage to the investment amount. With effect from 1 October 2013 if the average of relevant fees exceeds 3.0 per cent of the total invested into new portfolio companies and 2.0 per cent into follow-on investments over the Company's financial year, this excess will be rebated to the Company. As at 31 December 2014, the Company was due a rebate from the Investment Adviser of £4,000 (2013: £12,000).

Monitoring and directors fees the Investment Adviser receives from the investee companies are limited to a maximum of £40,000 (excluding VAT) per annum per company.

The total remuneration payable to YFM Private Equity Limited in the period was £754,000 (2013: £620,000).

Under the Subscription Rights Agreement dated 23 November 2001 between the Company, YFM Private Equity Limited and Chord Capital Limited (formerly Generics Asset Management Limited), as amended by an agreement between those parties dated 31 October 2005, YFM Private Equity and Chord have a performance-related incentive, structured so as to entitle them to an amount (satisfied by the issue by the Company of ordinary shares) equivalent to 20 per cent of the amount by which the cumulative cash dividends paid as at the last Business Day in December in any year plus the average of the middle market quotation per ordinary share exceeds 120 pence per ordinary share on that same day multiplied by the number of ordinary shares in issue and the shares under option (if any). The subscription rights were exercisable in the ration 59:41 between YFM Private Equity and Chord. By a Deed of Assignment dated 19 December 2003 (together with a supplemental agreement dated 5 October 2005), the benefit of the YFM Private Equity subscription right was assigned to YFM Private Equity Limited Carried Interest Trust (the "Trust"), an employee benefit trust formed for the benefit of certain employees of YFM Private Equity Limited and associated companies. Pursuant to a deed of variation dated 16 November 2012 between the Company, the trustees of the Trust and Chord, the Subscription Rights Agreement was varied so that the subscription rights will be exercisable in the ratio of 95:5 between the trustees of the Trust and Chord. Pursuant to a deed of variation dated 5 August 2014 the Subscription Rights Agreement was varied so that the recipient was changed from the Trust to YFM Private Equity. As at 31 December 2014 the total of cumulative cash dividends paid and mid-market price was 99.50 pence per ordinary share. No shares have been issued under this agreement.

Under the terms of the joint offer with British Smaller Companies VCT plc, launched on 14 January 2014  (which closed on 5 April 2014), YFM Private Equity Limited was entitled to 5.5 per cent of gross subscriptions from execution brokers and 3.5 per cent of gross subscriptions for applications through intermediaries offering financial advice or directly from applicants, less the cost of incentive shares and re-investment of intermediary commission. The net amount payable to YFM Private Equity amounted to £488,847 in total.

Under the terms of the offer with British Smaller Companies VCT plc, launched on 20 October 2014,  YFM Private Equity Limited was entitled to 5.0 per cent of gross subscriptions from execution brokers and 3.0 per cent of gross subscriptions for applications through intermediaries offering financial advice or directly from applicants, less the cost of incentive shares and re-investment of intermediary commission. The net amount payable to YFM Private Equity at the date of this report amounted to £280,985.

The Investment Adviser met all costs and expenses arising from these offers out of these fees, including any payment or re-investment of initial intermediary commissions (excluding permissible trail commission, which continues to be met by the Company).

The details of directors' remuneration are set out in the Directors' Remuneration Report on page 44  of the annual report under the heading "Directors' Remuneration for the year ended 31 December 2014 (audited)".

 

 

4             Taxation             

 


2014

2013


 

Revenue

£000

 

Capital

£000

 

Total

£000

 

Revenue

£000

 

Capital

£000

 

Total

£000








Corporation tax at 20% (2013: 20%)

-

-

-

-

-

-

Profit before taxation

697

460

1,157

208

1,923

2,131

Profit before taxation multiplied by standard small company rate of corporation tax in UK of 20% (2013: 20%)

 

 

139

 

 

92

 

 

231

 

 

42

 

 

385

 

 

427

Effect of:







UK dividends received

(41)

-

(41)

(17)

-

(17)

Non taxable profits on investments

-

(196)

(196)

-

(469)

(469)

Excess advisory expenses

(91)

97

6

(25)

84

59

Tax charge (credit)                                       

7

(7)

-

-

-

-








 

The Company has no provided or unprovided deferred tax liability in either year.

 

Deferred tax assets of £560,000 calculated at 20% (2013: £559,000) in respect of unrelieved advisory expenses (£2.799 million as at 31 December 2014 and £2.793 million as at 31 December 2013) have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which assets can be recovered.

 

Due to the Company's status as a venture capital trust and the continued intention to meet with the conditions required to comply with Section 274 of the Income Tax Act 2007, the Company has not provided for deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

 

5          Dividends

 



Amounts recognised as distributions to equity holders in the year to 31 December


 

Revenue

£000

2014

Capital

£000

 

Total

£000

 

Revenue

£000

2013

Capital

£000

 

Total

£000

Final dividend for 2013 of 2.5p (2012: 2.5p) per ordinary share

 

7

 

1,542

 

1,549

 

154

 

1,001

 

1,155

Interim dividend for 2014 of 2.0p (2013: 2.0p) per ordinary share

 

162

 

1,083

 

1,245

 

        129

 

799

 

928








                                                                                                         

169

2,625

2,794

283

1,800

2,083

Shares Issued under DRIS



(436)



(286)

Unclaimed dividends



(75)



-

Dividends paid in Statement of Cash Flows



2,283



1,797

 

The final year-end dividend of 2.5 pence per ordinary share in respect of the year to 31 December 2013 was paid on 30 June 2014 to shareholders on the register at 30 May 2014.

 

The interim dividend of 2.0 pence per ordinary share  was paid on 7 October 2014 to shareholders on the register as at 5 September 2014.

 

A final dividend of 2.5 pence per ordinary share in respect of the year to 31 December 2014 is proposed. This dividend has not been recognised in the year ended 31 December 2014 as the obligation did not exist at the balance sheet date.

 

During the year the Company has received £75,000 from the Registrars in respect of unclaimed dividends. These are held in a separate bank account until such time as contact can be made with the shareholders affected so that payment can be made to them.

                                                                                                                               

6             Basic and Diluted Earnings per Ordinary Share  

 

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to shareholders of £1,157,000 (2013: £2,131,000 profit) and 57,825,246 (2013: 45,070,587) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

The basic and diluted revenue earnings per ordinary share is based on the profit for the year attributable to shareholders of £690,000 (2013: £208,000) and 57,825,246 (2013: 45,070,587) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

The basic and diluted capital earnings per ordinary share is based on the capital profit for the year attributable to shareholders of £467,000 (2013: £1,923,000) and 57,825,246 (2013: 45,070,587) ordinary shares being the weighted average number of ordinary shares in issue during the year.

 

During the year the Company issued 16,245,613 ordinary shares. The Company has also repurchased 132,300 of  its own shares which are held in treasury. The treasury shares have been excluded in calculating the weighted average number of ordinary shares for the period that they were treasury shares.

 

The only potentially dilutive shares are those shares which, subject to certain criteria being achieved in the future, may be issued by the Company to meet its obligations under the IAA as set out in note 3. No such shares have been issued or are currently expected to be issued. There are, therefore, considered to be no potentially dilutive shares in issue at 31 December 2014 or 31 December 2013.

 

7              Financial Assets at Fair Value through Profit or Loss

 

Movements in investments at fair value through profit or loss during the year to 31 December 2014 are summarised as follows:

 

IFRS 13 measurement classification

Level 3

Level 1


Level 1


               

Unquoted 

investments

Quoted equity

investments

Total quoted and unquoted

Fixed income

securities

Total investments

 


£000

£000

£000

£000

£000







Opening cost

13,792

2,061

15,853

888

16,741

Opening investment holding (loss) gain

                (4)

              406

              402

                2

              404

Opening fair value at

 1 January 2014

13,788

2,467

16,255

890

17,145

Additions at cost

13,110

486

13,596

475

14,071

Capitalised interest

8

-

8

8

Disposal proceeds

(1,687)

(627)

(2,314)

(1,365)

(3,679)

Net profit on disposal*

501

59

560

560

Change in fair value in the year on assets held at 31 December 2014

 

368

 

(257)

 

111

 

 

111

Closing fair value at

31 December 2014

 

26,088

 

2,128

 

28,216

 

 

28,216







Closing cost

24,593

2,146

26,739

-

26,739

Closing investment holding gain (loss)

           1,495

              (18)

           1,477

                -

         1,477

Closing fair value at

31 December 2014

 

26,088

 

2,128

 

28,216

 

-

 

28,216

 

*The net profit on disposal in the table above is £560,000 whereas that shown in the Statement of Comprehensive Income  and the table on page 17 of the annual report is £870,000. The difference comprises deferred proceeds of £310,000 in respect of assets which  have been disposed and are not included within the investment portfolio at the year end.

Following the merger between the Company and British Smaller Technologies Company VCT plc a total of £975,000 of negative goodwill was recognised in the investment holding gains and losses reserve in respect of the investments acquired. The relevant amount per investment is realised, at the point of disposal to the capital reserve. At 31 December 2014 a total of £30,000 was held on investments yet to be realised in the investment holdings gains and losses reserve.

The total of fair value adjustments below cost made against unquoted investments during the year ended 31 December 2014 amounted to £766,000 (2013: £524,000).

There were no individual reductions in fair value during the year that exceeded five per cent of the total assets of the Company. In 2013 there were also no such individual reductions.



 

 

8             Basic and Diluted Net Asset Value per Ordinary Share   

 

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £39,333,000 (2013: £30,458,000) and 62,556,876 (2013: 46,443,563) ordinary shares in issue at the year end.  

 

The treasury shares have been excluded in calculating the number of ordinary shares in issue at 31 December 2014.

 

The only potentially dilutive shares are those shares which, subject to certain criteria being achieved in the future, may be issued by the Company to meet its obligations under the IAA as set out in note 3. No such shares have been issued or are currently expected to be issued. There are therefore considered to be no potentially dilutive shares in issue at 31 December 2014 or 31 December 2013. Consequently, basic and diluted net asset value per ordinary share is the same for the year ended 31 December 2014 and 31 December 2013. 

 

9             Total Return per Ordinary Share

 

The total return per ordinary share is calculated on cumulative dividends paid of 43.5 pence per ordinary share (2013: 39.0 pence per ordinary share) plus the net asset value as calculated per note 8.

 

 

10          Related Party Transactions

Mr R Last was appointed as chairman and non-executive director of Gamma Communications Limited ("Gamma") on 17 June 2014. On 10 October 2014 the ordinary shares of Gamma were admitted to trading on the AIM. As part of the placing of Gamma's ordinary shares Mr R Last invested £100,000, representing a 0.06 per cent equity stake in Gamma. During the year he received £43,750 from Gamma in respect of his services.

 

11          Events after the Balance Sheet Date

Following the period end an investment of £0.4 million has been made into quoted portfolio company Gooch & Housego plc, a company specialising in the design, manufacture and supply of fibre optic solutions such as optical components, photonic packaging and optoelectronic integration.

 

In the period since the year end the Company has also received £435,000 of monthly capital loan repayments from investee companies. The most significant of these was £303,000 received in February 2015 from DisplayPlan Holdings Limited as part of an early loan repayment agreed with the company.

 

Subsequent to the year end the Company allotted a total of 14,110,981 ordinary shares on 6 January 2015, 2 February 2015 and 2 March 2015 pursuant to the offer detailed under "Fundraising" above, raising net proceeds of £8.67m.

 

 

12          Financial Information

 

The financial information set out in this announcement for the year ended 31 December 2014 does not constitute full statutory accounts as defined in section 434 of the Companies Act 2006 but has been extracted from the Company's statutory accounts for that period. Statutory accounts for the year ended 31 December 2014 will be delivered to the Registrar of Companies following the Company's Annual General Meeting on 15 May 2015. Those accounts have been reported upon without qualification by the Company's independent auditor and did not contain a statement under Section 498(2) or (3) of the Companies Act 2006.

13          Annual Report and Accounts     

 

Copies of the statutory accounts for the year ended 31 December 2014 will shortly be submitted to the National Storage Mechanism and will be available to the public for viewing online at www.hemscott.com/msn/do.  They can also shortly be viewed on the Company's website at www.bscfunds.com. Hard copies of the statutory accounts for the year ended 31 December 2014 will be distributed by post to shareholders and will be available thereafter to members of the public from the Company's registered office.

14          Directors

 

The directors of the Company are Mr R Last, Mr R Pettigrew, and Mr P Waller.

 

15          Annual General Meeting

The Annual General Meeting of the Company will be held at 33 St James Square, London, SW1Y 4JS on 15 May 2015 at 12.00 noon.

16          Final Dividend for the year ended 31 December 2014      

Further to the announcement of its final results for the year ended 31 December 2014, the Company confirms that, subject to its approval by shareholders at the forthcoming Annual General Meeting to be held on 15  May 2015, the final dividend of 2.5 pence per ordinary share ("Final Dividend") will be paid on 8 June 2015 to those shareholders on the Company's register at the close of business on 8 May 2015. The ex-dividend date is 7 May 2015.

17          Dividend re-investment scheme ("DRIS")             

The Company operates a dividend reinvestment scheme ("DRIS"). The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Final Dividend is the close of business on 22 May 2015.

 

For further information, please contact:

 

David Hall                                         YFM Equity Partners Limited                         Tel:  0113 244 1000

Emily Watts                                       Nplus 1 Singer Advisory LLP                        Tel:  0207 496 3000

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PKADNCBKDCNB
UK 100

Latest directors dealings